|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| C07K 16/18 | (2013.01) | ||
| C07K 16/40 | (2006.01) | ||
| C07K 16/40 | (2013.01) | ||
| C12Q 1/6883 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| G01N 33/574 | (2013.01) | ||
| C12Q 1/6883 | (2018.01) | ||
| G01N 33/6893 | (2013.01) | ||
| G01N 33/68 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61P 7/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 37/00 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| G01N 33/574 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Patento numeris | 3630819 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18731616.1 |
| Europos patento paraiškos padavimo data | 2018-05-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/033678 |
| Data | 2018-05-21 |
| (87) | Numeris | WO 2018/217638 |
| Data | 2018-11-29 |
| (30) | Numeris | Data | Šalis |
| 201762509576 P | 2017-05-22 | US |
| (72) |
ADIV, Orly, Eshach , IL
BEDROSIAN, Camille , US
FELDMAN, Hagit, Baris , US
KUROLAP, Alina , IL
MCKNIGHT, Susan, Faas , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS |
| DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS |